Received: 24 October 2020
Accepted: 13 January 2021
First Online: 8 February 2021
Ethics approval and consent to participate
: The study was approved by the Audit office at Beaumont Hospital, Dublin, Ireland. This approval included all administrative permissions necessary to access and use the study administrative data. As a retrospective study, no informed consent was obtained. This is in compliance with National Guidelines as indicated by the Health Research Consent Declaration Committee on Retrospective Chart Review (Updated August 30th, 2019) [CitationRef removed].
: Not applicable.
: PGM received travel support from Roche, Novartis, Amgen. PGM received honoraria from Astellas, Novartis, Pfizer, Teva, Nordic, Bristol Meyers Squibb, Astra Zeneca, Genomic health, Roche. PGM has a consultancy/advisory role with Novartis. PGM has had a speaker role with Teva. PGM received research funding from Teva and Genomic Health however no funding was obtained for this study. All other authors declare that they have no competing interests.